Possible and appropriate foreign market entry modes for PharmaUK to launch NovaRelief in India. An analysis

Seminar paper from the year 2015 in the subject Economics - International Economic Relations, grade: 78% = 1,3, Kingston University London, language: English, abstract: This business report analyses four possible foreign market entry modes for a small pharmaceutical UK firm called "PharmaUK" and recommends which one of the entry mode options PharmaUK should adopt for entering India. PharmaUK has recently developed a new type of painkiller medication called "NovaRelief" by using its unique knowledge and technology. As it is a new type of painkiller medication, it can be considered to be a "new drug", meaning that it has not been used in India before. PharmaUK has decided to launch its new product in India. This report starts with presenting the key factors of India as a new foreign market followed by comparing and contrasting the four possible entry modes for PharmaUK. In the end, a recommendation on which entry mode to choose is given.